H&Q Korea acquisition of Ildong Pharmaceutical

Overview:

• H&Q Korea, a domestic private equity fund, has acquired Ildong Pharmaceutical from Green Cross for $120 million.
• H&Q Asia-Pacific has invested in over 400 companies at an aggregate of over $3.4 billion.
• Ildong is a Korean pharmaceutical company engaged in the development of new drugs and is globalising through joint ventures. 

Katrin Kostadinova - Data analyst